CLINICAL_TRIALS
trial_result
· 2017-05-03
Clinical Trial Update: Delayed Release Prednisone in PMR [Phase 2]
Summary
A Phase 2 study evaluating delayed-release prednisone for polymyalgia rheumatica has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dinora, Inc. | Conditions: Polymyalgia Rheumatica | Phase 2 | Status: TERMINATED